The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Abeona Therapeutics Inc COM 00289Y107 8,150 2,859,767 SH   SOLE   2,859,767 0 0
Aldeyra Therapeutics Inc COM 01438T106 2,374 569,405 SH   SOLE   569,405 0 0
Anavex Life Sciences Corp COM NEW 032797300 3,621 724,205 SH   SOLE   724,205 0 0
Applied Therapeutics Inc COM 03828A101 22,992 650,238 SH   SOLE   650,238 0 0
Biohaven Pharmactl Hldg Co L COM G11196105 62,074 857,494 SH   SOLE   857,494 0 0
BioXCel Therapeutics Inc COM 09075P105 1,070 20,000 SH   SOLE   20,000 0 0
Blackstone Group LP COM UNIT LTD 09253U108 2,246 40,000 SH   SOLE   40,000 0 0
Catasys Inc COM PAR 149049504 1,097 43,034 SH   SOLE   43,034 0 0
Centurylink Inc COM 156700106 2,171 220,000 SH   SOLE   220,000 0 0
Corbus Pharmaceuticals HLDGS COM 21833P103 42,335 5,045,870 SH   SOLE   5,045,870 0 0
Corteva Inc COM 22052L104 811 30,000 SH   SOLE   30,000 0 0
Dow Inc COM 260557103 1,223 30,000 SH   SOLE   30,000 0 0
Dupont de Nemours Inc COM 26614N102 785 15,000 SH   SOLE   15,000 0 0
Eiger Biopharmaceuticals Inc COM 28249U105 5,063 525,238 SH   SOLE   525,238 0 0
Entera Bio Ltd SHS M40527109 3,013 1,741,363 SH   SOLE   1,741,363 0 0
Exicure Inc COM 30205M101 3,067 1,277,777 SH   SOLE   1,277,777 0 0
Molecular Templates COM 608550109 1,540 113,905 SH   SOLE   113,905 0 0
Orgenesis, Inc. COM 68619K105 8,003 1,316,364 SH   SOLE   1,316,364 0 0
Soligenix Inc. COM 834223307 1,584 787,830 SH   SOLE   787,830 0 0